Increased expression of telomere-regulating genes in endurance athletes with long leukocyte telomeres

Journal of Applied Physiology

Volumn 120, Issue 2, 2016, Pages 148-158

  Denham, Joshua ^a,b   O'Brien, Brendan J ^b   Prestes, Priscilla R ^b   Brown, Nicholas J ^b   Charchar, Fadi J ^b  

^a UNIVERSITY OF NEW ENGLAND   (Australia)

^b UNIVERSITY OF BALLARAT   (Australia)

Author keywords

Resting heart rate; Shelterin; Sitting; TERT; VO2 max

Indexed keywords

MESSENGER RNA;

ADULT; AGING; ATHLETE; ENDURANCE; EXERCISE; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; LEUKOCYTE; MALE; METABOLISM; PHYSIOLOGY; RUNNING; TELOMERE; UPREGULATION;

ADULT; AGING; ATHLETES; EXERCISE; FEMALE; GENE EXPRESSION; HUMANS; LEUKOCYTES; MALE; PHYSICAL ENDURANCE; RNA, MESSENGER; RUNNING; TELOMERE; UP-REGULATION;

EID: 84969373495     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00587.2015     Document Type: Article

References (75)

1. Allsopp RC, Chang E, Kashefi-Aazam M, Rogaev EI, Piatyszek MA, Shay JW, Harley CB. Telomere shortening is associated with cell division in vitro and in vivo. Exp Cell Res 220: 194-200, 1995.
2. An P, Rice T, Gagnon J, Borecki IB, Perusse L, Leon AS, Skinner JS, Wilmore JH, Bouchard C, Rao DC. Familial aggregation of resting blood pressure and heart rate in a sedentary population: the HERITAGE Family Study. Health, Risk Factors, Exercise Training, and Genetics. Am J Hypertens 12: 264-270, 1999.
3. Aviv A. Genetics of leukocyte telomere length and its role in atherosclerosis. Mutat Res 730: 68-74, 2012.
4. Baragetti A, Palmen J, Garlaschelli K, Grigore L, Pellegatta F, Tragni E, Catapano AL, Humphries SE, Norata GD, Talmud PJ. Telomere shortening over 6 years is associated with increased subclinical carotid vascular damage and worse cardiovascular prognosis in the general population. J Intern Med 277: 478-487, 2015.
5. Booth M. Assessment of physical activity: an international perspective. Res Q Exerc Sport 71: S114-120, 2000.
6. 2 max in the sedentary state: the HERITAGE family study. Med Sci Sports Exerc 30: 252-258, 1998.
7. Brouilette SW, Moore JS, McMahon AD, Thompson JR, Ford I, Shepherd J, Packard CJ, Samani NJ; West of Scotland Coronary Prevention Study Group. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet 369: 107-114, 2007.
8. Carter JB, Banister EW, Blaber AP. Effect of endurance exercise on autonomic control of heart rate. Sports Med 33: 33-46, 2003.
9. Chen JL, Blasco MA, Greider CW. Secondary structure of vertebrate telomerase RNA. Cell 100: 503-514, 2000.
10. Chen K, Keaney JF Jr. Evolving concepts of oxidative stress and reactive oxygen species in cardiovascular disease. Curr Atheroscler Rep 14: 476-483, 2012.
11. Cherkas LF, Hunkin JL, Kato BS, Richards JB, Gardner JP, Surdulescu GL, Kimura M, Lu X, Spector TD, Aviv A. The association between physical activity in leisure time and leukocyte telomere length. Arch Intern Med 168: 154-158, 2008.
12. Chilton WL, Marques FZ, West J, Kannourakis G, Berzins SP, O'Brien BJ, Charchar FJ. Acute exercise leads to regulation of telomere-associated genes and microRNA expression in immune cells. PLoS One 9: e92088, 2014.
13. Chiu CP, Harley CB. Replicative senescence and cell immortality: the role of telomeres and telomerase. Proc Soc Exp Biol Med 214: 99-106, 1997.
14. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 24: 385-396, 1983.
15. Dalageorgou C, Ge D, Jamshidi Y, Nolte IM, Riese H, Savelieva I, Carter ND, Spector TD, Snieder H. Heritability of QT interval: how much is explained by genes for resting heart rate? J Cardiovasc Electrophysiol 19: 386-391, 2008.
16. Deelen J, Beekman M, Codd V, Trompet S, Broer L, Hagg S, Fischer K, Thijssen PE, Suchiman HE, Postmus I, Uitterlinden AG, Hofman A, de Craen AJ, Metspalu A, Pedersen NL, van Duijn CM, Jukema JW, Houwing-Duistermaat JJ, Samani NJ, Slagboom PE. Leukocyte telomere length associates with prospective mortality independent of immune-related parameters and known genetic markers. Int J Epidemiol 43: 878-886, 2014.
17. Denham J, Marques FZ, Charchar FJ. Leukocyte telomere length variation due to DNA extraction method. BMC Res Notes 7: 877, 2014.
18. Denham J, Nelson CP, O'Brien BJ, Nankervis SA, Denniff M, Harvey JT, Marques FZ, Codd V, Zukowska-Szczechowska E, Samani NJ, Tomaszewski M, Charchar FJ. Longer leukocyte telomeres are associated with ultra-endurance exercise independent of cardiovascular risk factors. PLoS One 8: e69377, 2013.
19. Denham J, O'Brien BJ, Marques FZ, Charchar FJ. Changes in the leukocyte methylome and its effect on cardiovascular-related genes after exercise. J Appl Physiol (1985) 118: 475-488, 2015.
20. Du M, Prescott J, Kraft P, Han J, Giovannucci E, Hankinson SE, De Vivo I. Physical activity, sedentary behavior, and leukocyte telomere length in women. Am J Epidemiol 175: 414-422, 2012.
21. Epel ES, Blackburn EH, Lin J, Dhabhar FS, Adler NE, Morrow JD, Cawthon RM. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci USA 101: 17312-17315, 2004.
22. Gomes EC, Silva AN, de Oliveira MR. Oxidants, antioxidants, and the beneficial roles of exercise-induced production of reactive species. Oxid Med Cell Longev 2012: 756132, 2012.
23. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43: 405-413, 1985.
24. Hande MP, Samper E, Lansdorp P, Blasco MA. Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice. J Cell Biol 144: 589-601, 1999.
25. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 345: 458-460, 1990.
26. Hemann MT, Strong MA, Hao LY, Greider CW. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107: 67-77, 2001.
27. Jensen MT, Marott JL, Allin KH, Nordestgaard BG, Jensen GB. Resting heart rate is associated with cardiovascular and all-cause mortality after adjusting for inflammatory markers: the Copenhagen City Heart Study. Eur J Prev Cardiol 19: 102-108, 2012.
28. Kaptoge S, Seshasai SR, Gao P, Freitag DF, Butterworth AS, Borglykke A, Di Angelantonio E, Gudnason V, Rumley A, Lowe GD, Jorgensen T, Danesh J. Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis. Eur Heart J 35: 578-589, 2014.
29. Kimura M, Gazitt Y, Cao X, Zhao X, Lansdorp PM, Aviv A. Synchrony of telomere length among hematopoietic cells. Exp Hematol 38: 854-859, 2010.
30. Knez WL, Coombes JS, Jenkins DG. Ultra-endurance exercise and oxidative damage: implications for cardiovascular health. Sports Med 36: 429-441, 2006.
31. Krauss J, Farzaneh-Far R, Puterman E, Na B, Lin J, Epel E, Blackburn E, Whooley MA. Physical fitness and telomere length in patients with coronary heart disease: findings from the Heart and Soul Study. PLoS One 6: e26983, 2011.
32. Kurz DJ, Decary S, Hong Y, Trivier E, Akhmedov A, Erusalimsky JD. Chronic oxidative stress compromises telomere integrity and accelerates the onset of senescence in human endothelial cells. J Cell Sci 117: 2417-2426, 2004.
33. LaRocca TJ, Seals DR, Pierce GL. Leukocyte telomere length is preserved with aging in endurance exercise-trained adults and related to maximal aerobic capacity. Mech Ageing Dev 131: 165-167, 2010.
34. Laye MJ, Solomon TP, Karstoft K, Pedersen KK, Nielsen SD, Pedersen BK. Increased shelterin mRNA expression in peripheral blood mononuclear cells and skeletal muscle following an ultra-long-distance running event. J Appl Physiol (1985) 112: 773-781, 2012.
35. Lee DC, Pate RR, Lavie CJ, Sui X, Church TS, Blair SN. Leisure-time running reduces all-cause and cardiovascular mortality risk. J Am Coll Cardiol 64: 472-481, 2014.
36. Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CB. Telomere end-replication problem and cell aging. J Mol Biol 225: 951-960, 1992.
37. Libby P. Inflammation in atherosclerosis. Nature 420: 868-874, 2002.
38. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2[-delta delta C(T)] method. Methods 25: 402-408, 2001.
39. Loprinzi PD, Loenneke JP, Blackburn EH. Movement-based behaviors and leukocyte telomere length among U.S. adults. Med Sci Sports Exerc 47: 2347-2352, 2015.
40. Ludlow AT, Lima LC, Wang J, Hanson ED, Guth LM, Spangenburg EE, Roth SM. Exercise alters mRNA expression of telomere-repeat binding factor 1 in skeletal muscle via p38 MAPK. J Appl Physiol (1985) 113: 1737-1746, 2012.
41. Ludlow AT, Zimmerman JB, Witkowski S, Hearn JW, Hatfield BD, Roth SM. Relationship between physical activity level, telomere length, and telomerase activity. Med Sci Sports Exerc 40: 1764-1771, 2008.
42. Mainous AG 3rd, Codd V, Diaz VA, Schoepf UJ, Everett CJ, Player MS, Samani NJ. Leukocyte telomere length and coronary artery calcification. Atherosclerosis 210: 262-267, 2010.
43. Masi S, D'Aiuto F, Martin-Ruiz C, Kahn T, Wong A, Ghosh AK, Whincup P, Kuh D, Hughes A, von Zglinicki T, Hardy R, Deanfield JE; NSHD scientific and data collection teams. Rate of telomere shortening and cardiovascular damage: a longitudinal study in the 1946 British Birth Cohort. Eur Heart J 35: 3296-3303, 2014.
44. Mason C, Risques RA, Xiao L, Duggan CR, Imayama I, Campbell KL, Kong A, Foster-Schubert KE, Wang CY, Alfano CM, Blackburn GL, Rabinovitch PS, McTiernan A. Independent and combined effects of dietary weight loss and exercise on leukocyte telomere length in postmenopausal women. Obesity (Silver Spring) 21: E549-554, 2013.
45. Millet GP, Vleck VE, Bentley DJ. Physiological differences between cycling and running: lessons from triathletes. Sports Med 39: 179-206, 2009.
46. Nandakumar J, Cech TR. Finding the end: recruitment of telomerase to telomeres. Nat Rev Mol Cell Biol 14: 69-82, 2013.
47. O'Donnell CJ, Demissie S, Kimura M, Levy D, Gardner JP, White C, D'Agostino RB, Wolf PA, Polak J, Cupples LA, Aviv A. Leukocyte telomere length and carotid artery intimal medial thickness: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 28: 1165-1171, 2008.
48. Oliveira-Sales EB, Nishi EE, Carillo BA, Boim MA, Dolnikoff MS, Bergamaschi CT, Campos RR. Oxidative stress in the sympathetic premotor neurons contributes to sympathetic activation in renovascular hypertension. Am J Hypertens 22: 484-492, 2009.
49. Ornish D, Lin J, Chan JM, Epel E, Kemp C, Weidner G, Marlin R, Frenda SJ, Magbanua MJ, Daubenmier J, Estay I, Hills NK, Chainani-Wu N, Carroll PR, Blackburn EH. Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet Oncol 14: 1112-1120, 2013.
50. Osthus IB, Sgura A, Berardinelli F, Alsnes IV, Bronstad E, Rehn T, Stobakk PK, Hatle H, Wisloff U, Nauman J. Telomere length and long-term endurance exercise: does exercise training affect biological age? A pilot study. PLoS One 7: e52769, 2012.
51. Palm W, de Lange T. How shelterin protects mammalian telomeres. Annu Rev Genet 42: 301-334, 2008.
52. Puterman E, Lin J, Blackburn E, O'Donovan A, Adler N, Epel E. The power of exercise: buffering the effect of chronic stress on telomere length. PLoS One 5: e10837, 2010.
53. Rode L, Nordestgaard BG, Bojesen SE. Peripheral blood leukocyte telomere length and mortality among 64,637 individuals from the general population. J Natl Cancer Inst 107: djv074, 2015.
54. Salpea KD, Maubaret CG, Kathagen A, Ken-Dror G, Gilroy DW, Humphries SE. The effect of pro-inflammatory conditioning and/or high glucose on telomere shortening of aging fibroblasts. PLoS One 8: e73756, 2013.
55. Salpea KD, Talmud PJ, Cooper JA, Maubaret CG, Stephens JW, Abelak K, Humphries SE. Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation. Atherosclerosis 209: 42-50, 2010.
56. Samani NJ, Boultby R, Butler R, Thompson JR, Goodall AH. Telomere shortening in atherosclerosis. Lancet 358: 472-473, 2001.
57. Samper E, Flores JM, Blasco MA. Restoration of telomerase activity rescues chromosomal instability and premature aging in Terc-/- mice with short telomeres. EMBO Rep 2: 800-807, 2001.
58. Sattelmair J, Pertman J, Ding EL, Kohl HW, Haskell W 3rd, Lee IM. Dose response between physical activity and risk of coronary heart disease: a meta-analysis. Circulation 124: 789-795, 2011.
59. Savela S, Saijonmaa O, Strandberg TE, Koistinen P, Strandberg AY, Tilvis RS, Pitkala KH, Miettinen TA, Fyhrquist F. Physical activity in midlife and telomere length measured in old age. Exp Gerontol 48: 81-84, 2013.
60. Saxena A, Minton D, Lee DC, Sui X, Fayad R, Lavie CJ, Blair SN. Protective role of resting heart rate on all-cause and cardiovascular disease mortality. Mayo Clin Proc 88: 1420-1426, 2013.
61. Sfeir A, de Lange T. Removal of shelterin reveals the telomere end-protection problem. Science 336: 593-597, 2012.
62. Shephard RJ, Balady GJ. Exercise as cardiovascular therapy. Circulation 99: 963-972, 1999.
63. Shiels PG, McGlynn LM, MacIntyre A, Johnson PC, Batty GD, Burns H, Cavanagh J, Deans KA, Ford I, McConnachie A, McGinty A, McLean JS, Millar K, Sattar N, Tannahill C, Velupillai YN, Packard CJ. Accelerated telomere attrition is associated with relative household income, diet and inflammation in the pSoBid cohort. PLoS One 6: e22521, 2011.
64. Singh JP, Larson MG, O'Donnell CJ, Tsuji H, Evans JC, Levy D. Heritability of heart rate variability: the Framingham Heart Study. Circulation 99: 2251-2254, 1999.
65. Sjogren P, Fisher R, Kallings L, Svenson U, Roos G, Hellenius ML. Stand up for health-avoiding sedentary behaviour might lengthen your telomeres: secondary outcomes from a physical activity RCT in older people. Br J Sports Med 48: 1407-1409, 2014.
66. Tardif JC. Heart rate as a treatable cardiovascular risk factor. Br Med Bull 90: 71-84, 2009.
67. Tomaszewski M, Charchar FJ, Przybycin M, Crawford L, Wallace AM, Gosek K, Lowe GD, Zukowska-Szczechowska E, Grzeszczak W, Sattar N, Dominiczak AF. Strikingly low circulating CRP concentrations in ultramarathon runners independent of markers of adiposity: how low can you go? Arterioscler Thromb Vasc Biol 23: 1640-1644, 2003.
68. Valdes AM, Andrew T, Gardner JP, Kimura M, Oelsner E, Cherkas LF, Aviv A, Spector TD. Obesity, cigarette smoking, and telomere length in women. Lancet 366: 662-664, 2005.
69. Vaziri H, Benchimol S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol 8: 279-282, 1998.
70. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci 27: 339-344, 2002.
71. von Zglinicki T, Martin-Ruiz CM. Telomeres as biomarkers for ageing and age-related diseases. Curr Mol Med 5: 197-203, 2005.
72. Wang F, Podell ER, Zaug AJ, Yang Y, Baciu P, Cech TR, Lei M. The POT1-TPP1 telomere complex is a telomerase processivity factor. Nature 445: 506-510, 2007.
73. Werner C, Furster T, Widmann T, Poss J, Roggia C, Hanhoun M, Scharhag J, Buchner N, Meyer T, Kindermann W, Haendeler J, Bohm M, Laufs U. Physical exercise prevents cellular senescence in circulating leukocytes and in the vessel wall. Circulation 120: 2438-2447, 2009.
74. Werner C, Hanhoun M, Widmann T, Kazakov A, Semenov A, Poss J, Bauersachs J, Thum T, Pfreundschuh M, Muller P, Haendeler J, Bohm M, Laufs U. Effects of physical exercise on myocardial telomere-regulating proteins, survival pathways, and apoptosis. J Am Coll Cardiol 52: 470-482, 2008.
75. Willeit P, Willeit J, Brandstatter A, Ehrlenbach S, Mayr A, Gasperi A, Weger S, Oberhollenzer F, Reindl M, Kronenberg F, Kiechl S. Cellular aging reflected by leukocyte telomere length predicts advanced atherosclerosis and cardiovascular disease risk. Arterioscler Thromb Vasc Biol 30: 1649-1656, 2010.